Mucinous and Non-Mucinous Rectal Adenocarcinoma—Differences in Treatment Response to Preoperative Radiotherapy

There is a need to personalize the treatment for rectal cancer patients. The aim of this study was to analyze therapy response and prognosis after preoperative radiotherapy in rectal cancer patients with mucinous adenocarcinoma compared to those with non-mucinous adenocarcinoma. The study included r...

Full description

Bibliographic Details
Main Authors: Karolina Vernmark, Xiao-Feng Sun, Annica Holmqvist
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Journal of Personalized Medicine
Subjects:
Online Access:https://www.mdpi.com/2075-4426/10/4/226
_version_ 1797547996473196544
author Karolina Vernmark
Xiao-Feng Sun
Annica Holmqvist
author_facet Karolina Vernmark
Xiao-Feng Sun
Annica Holmqvist
author_sort Karolina Vernmark
collection DOAJ
description There is a need to personalize the treatment for rectal cancer patients. The aim of this study was to analyze therapy response and prognosis after preoperative radiotherapy in rectal cancer patients with mucinous adenocarcinoma compared to those with non-mucinous adenocarcinoma. The study included retrospectively collected data from 433 patients, diagnosed with rectal cancer in the South East health care region in Sweden between 2004 and 2012. Patients with non-mucinous adenocarcinoma that received short-course radiotherapy before surgery had better overall survival, cancer specific survival, and disease-free survival, as well as distant- and local-recurrence-free survival (<i>p</i> = 0.003, <i>p</i> = 0.001, <i>p</i> = 0.002, <i>p</i> = 0.002, and <i>p</i> = 0.033, respectively) compared to the patients that received long-course radiotherapy with concomitant capecitabine. The results were still significant after adjusting for sex, age, stage, differentiation, and chemotherapy in the neoadjuvant and/or adjuvant setting, except for local-recurrence-free survival that was trending towards significance (<i>p</i> = 0.070). In patients with mucinous adenocarcinoma, no difference in survival was seen when comparing patients that had short-course radiotherapy and patients that had long-course radiotherapy. However, none of 18 patients with mucinous adenocarcinoma treated with long-course radiotherapy had local tumor progression, compared to 7% of 67 patients with non-mucinous adenocarcinoma. The results indicate that mucinous adenocarcinoma and non-mucinous adenocarcinoma may respond differently to radiotherapy.
first_indexed 2024-03-10T14:53:04Z
format Article
id doaj.art-a2df35d1703349ca9f041a36bc2ab624
institution Directory Open Access Journal
issn 2075-4426
language English
last_indexed 2024-03-10T14:53:04Z
publishDate 2020-11-01
publisher MDPI AG
record_format Article
series Journal of Personalized Medicine
spelling doaj.art-a2df35d1703349ca9f041a36bc2ab6242023-11-20T20:49:59ZengMDPI AGJournal of Personalized Medicine2075-44262020-11-0110422610.3390/jpm10040226Mucinous and Non-Mucinous Rectal Adenocarcinoma—Differences in Treatment Response to Preoperative RadiotherapyKarolina Vernmark0Xiao-Feng Sun1Annica Holmqvist2Department of Biomedical and Clinical Sciences, Linköping University, 58183 Linköping, SwedenDepartment of Biomedical and Clinical Sciences, Linköping University, 58183 Linköping, SwedenDepartment of Biomedical and Clinical Sciences, Linköping University, 58183 Linköping, SwedenThere is a need to personalize the treatment for rectal cancer patients. The aim of this study was to analyze therapy response and prognosis after preoperative radiotherapy in rectal cancer patients with mucinous adenocarcinoma compared to those with non-mucinous adenocarcinoma. The study included retrospectively collected data from 433 patients, diagnosed with rectal cancer in the South East health care region in Sweden between 2004 and 2012. Patients with non-mucinous adenocarcinoma that received short-course radiotherapy before surgery had better overall survival, cancer specific survival, and disease-free survival, as well as distant- and local-recurrence-free survival (<i>p</i> = 0.003, <i>p</i> = 0.001, <i>p</i> = 0.002, <i>p</i> = 0.002, and <i>p</i> = 0.033, respectively) compared to the patients that received long-course radiotherapy with concomitant capecitabine. The results were still significant after adjusting for sex, age, stage, differentiation, and chemotherapy in the neoadjuvant and/or adjuvant setting, except for local-recurrence-free survival that was trending towards significance (<i>p</i> = 0.070). In patients with mucinous adenocarcinoma, no difference in survival was seen when comparing patients that had short-course radiotherapy and patients that had long-course radiotherapy. However, none of 18 patients with mucinous adenocarcinoma treated with long-course radiotherapy had local tumor progression, compared to 7% of 67 patients with non-mucinous adenocarcinoma. The results indicate that mucinous adenocarcinoma and non-mucinous adenocarcinoma may respond differently to radiotherapy.https://www.mdpi.com/2075-4426/10/4/226mucinous adenocarcinomanon-mucinous adenocarcinomaradiotherapyrectal cancersurvival
spellingShingle Karolina Vernmark
Xiao-Feng Sun
Annica Holmqvist
Mucinous and Non-Mucinous Rectal Adenocarcinoma—Differences in Treatment Response to Preoperative Radiotherapy
Journal of Personalized Medicine
mucinous adenocarcinoma
non-mucinous adenocarcinoma
radiotherapy
rectal cancer
survival
title Mucinous and Non-Mucinous Rectal Adenocarcinoma—Differences in Treatment Response to Preoperative Radiotherapy
title_full Mucinous and Non-Mucinous Rectal Adenocarcinoma—Differences in Treatment Response to Preoperative Radiotherapy
title_fullStr Mucinous and Non-Mucinous Rectal Adenocarcinoma—Differences in Treatment Response to Preoperative Radiotherapy
title_full_unstemmed Mucinous and Non-Mucinous Rectal Adenocarcinoma—Differences in Treatment Response to Preoperative Radiotherapy
title_short Mucinous and Non-Mucinous Rectal Adenocarcinoma—Differences in Treatment Response to Preoperative Radiotherapy
title_sort mucinous and non mucinous rectal adenocarcinoma differences in treatment response to preoperative radiotherapy
topic mucinous adenocarcinoma
non-mucinous adenocarcinoma
radiotherapy
rectal cancer
survival
url https://www.mdpi.com/2075-4426/10/4/226
work_keys_str_mv AT karolinavernmark mucinousandnonmucinousrectaladenocarcinomadifferencesintreatmentresponsetopreoperativeradiotherapy
AT xiaofengsun mucinousandnonmucinousrectaladenocarcinomadifferencesintreatmentresponsetopreoperativeradiotherapy
AT annicaholmqvist mucinousandnonmucinousrectaladenocarcinomadifferencesintreatmentresponsetopreoperativeradiotherapy